Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Montpellier
The risk associated with a genetic predisposition is among the various forms of risk, the strongest identifiable risk . It enables to offer people at risk an appropriate medical care (screening, prevention ) the clinical benefit is validated today. The person with whom a predisposing mutation has been identified must communicated its related information on the risk of cancer and the ability to perform genetic analysis. It appears that this dissemination of information is not always optimal, as shown in figures from the National Cancer Institute joined the project; the purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient having a deleterious genetic mutation on genes BRCA1 and/or BRCA2 and or on genes MMR
The patient being of the family (who carried out a full analysis of BRCA1/BRCA2 and/or those MMR )
You may not be if
Patient not carrying a deleterious genetic mutation on the BRCA1/2 genes and/or those of the MMR system,
Patient under guardianship, curator or unable to give his non-opposition,